Artemisinin News and Research

RSS
Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. The compound (a sesquiterpene lactone) is isolated from the plant Artemisia annua. Not all plants of this species contain artemisinin.
Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Sanofi, PATH announce delivery of first large-scale batches of antimalarial treatments

Sanofi, PATH announce delivery of first large-scale batches of antimalarial treatments

Combination therapy effective in treating drug-resistant malaria

Combination therapy effective in treating drug-resistant malaria

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Malaria: Over half of Africa's population still live in high-risk infection areas

Malaria: Over half of Africa's population still live in high-risk infection areas

Ajoene in garlic prevents bacteria from destroying white blood cells

Ajoene in garlic prevents bacteria from destroying white blood cells

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

Researchers discover way to identify artemisinin-resistant malaria

Researchers discover way to identify artemisinin-resistant malaria

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

Scientists develop novel, rapid way to test artemisinin-resistant malaria

Scientists develop novel, rapid way to test artemisinin-resistant malaria

Test-based approach of WHO unsuitable for regions where lot of malaria occurs: Research

Test-based approach of WHO unsuitable for regions where lot of malaria occurs: Research

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

Discovery could reveal potential new drug options for malaria treatment

Discovery could reveal potential new drug options for malaria treatment

U.N. urges sustained support for prevention, treatment activities on World Malaria Day

U.N. urges sustained support for prevention, treatment activities on World Malaria Day

U.S. CDC, FDA, armed forces taking action to fight malaria

U.S. CDC, FDA, armed forces taking action to fight malaria

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion